Pharmaceutical advertisement claims in Australian medical publications.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 12225274.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
OBJECTIVE: To determine the quality of claims in advertisements published in Australian medical publications, describe how benefits and harms are presented, and examine the level of underpinning evidence. DESIGN AND SETTING: Audit of a consecutive three-month sample of advertisements appearing in six popular Australian medical publications. MAIN OUTCOME MEASURES: Proportion of advertisements with quantitative information; proportion of claims conveying clinical outcomes; where retrievable, level of underpinning evidence. RESULTS: Of 1504 claims, 855 could be substantiated quantitatively. Of these, 45% were supported by compelling evidence (randomised controlled trials or better). Of 13 claims explicitly reporting quantitative outcomes, none provided the absolute risk reduction or the number needed to treat. CONCLUSIONS: Our audit invites greater diligence by pharmaceutical companies in substantiating their claims and greater vigilance among clinicians when reading them.